ArthroCare R Corp. Nasdaq:ARTC , a multi-business medical device company that develops minimally invasive surgical products, announced today Drs. The Webcast is designed to demonstrate the improved clinical outcomes that result from these advanced surgical techniques. A camera crew will provide complete access to the operating theater during the Webcast and live audio will be featured from within the operating room. Timms is a registered nurse with extensive pre- and post-operative experience with the Coblation techniques.
|Published (Last):||20 November 2016|
|PDF File Size:||8.81 Mb|
|ePub File Size:||17.57 Mb|
|Price:||Free* [*Free Regsitration Required]|
This device can be used prior to common procedures including the treatment of spinal diseases requiring bone augmentation and percutaneous cement injection. Baker, president and chief executive officer for ArthroCare. Bassem A. Georgy, assistant clinical professor in the department of interventional radiology at the University of California, San Diego, recently treated a small series of patients using ArthroCare's Coblation technology to dissolve tissue growths in the spine.
ArthroCare Corp. Coblation uses low-temperature radiofrequency energy to gently and precisely dissolve rather than burn soft tissue, minimizing damage to healthy tissue. ArthroCare targets a multi-billion dollar market opportunity across several medical specialties, significantly improving surgical procedures and enabling new, minimally invasive procedures.
ArthroCare's Coblation-based devices have been used in more than two million surgical procedures worldwide. Except for historical information, this press release includes forward-looking statements. These statements include, but are not limited to, the expectations regarding trends in newly commercialized markets, the company's belief that certain surgical products and procedures will enhance achievement of the company's long-term potential, the sustainability of growth rates in certain markets, the effect of anticipated government regulatory clearances, continued success of product diversification efforts, opportunities to execute strategic initiatives, and other statements that involve risks and uncertainties.
These risks and uncertainties include, but are not limited to, the fact that the company's operating results will fluctuate, the market price of the company's stock may be highly volatile, the sustainability of the company's growth rate, continued success of market diversification efforts.
These and other risks and uncertainties are detailed from time to time in the company's Securities and Exchange Commission filings, including ArthroCare's Form K for the year ended December 31, and the Q for the quarter ended June 30, Forward-looking statements are indicated by words or phrases such as "anticipates", "estimates", "projects", "believes", "intends", "expects", and similar words and phrases. Actual results may differ materially from management plans.
Safe Harbor Statements Except for historical information, this press release includes forward-looking statements. Log In Sign Up.